Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo

Estrogen receptor negative (ER(−)) breast cancer is aggressive, responds poorly to current treatments and has a poor prognosis. The NF-κB signaling pathway is implicated in ER(−) tumorigenesis. Aspirin (ASA) is chemopreventive against ER(+) but not for ER(−) breast cancers. Nitric oxide-releasing as...

Descripción completa

Detalles Bibliográficos
Autores principales: Nath, Niharika, Chattopadhyay, Mitali, Rodes, Deborah B., Nazarenko, Anna, Kodela, Ravinder, Kashfi, Khosrow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331965/
https://www.ncbi.nlm.nih.gov/pubmed/26184135
http://dx.doi.org/10.3390/molecules200712481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331965/
https://www.ncbi.nlm.nih.gov/pubmed/26184135
http://dx.doi.org/10.3390/molecules200712481

Ejemplares similares